The Role of New Serogroup B Vaccines in Preventing Meningitis Outbreaks

NFID experts, Carol J. Baker, MD, Lorry G. Rubin, MD, and William Schaffner, MD, will discuss unique challenges of meningococcal disease, new ACIP recommendations for serogroup B vaccine use, and considerations for future recommendations.
At the conclusion of the webinar, participants will be able to:

Describe meningococcal disease morbidity and mortality and current epidemiology
Discuss US immunization recommendations for use of the quadrivalent (A,C,W,Y) and monovalent (B) meningococcal vaccines
List environmental and behavioral risk factors that increase risk of meningococcal disease for adolescents

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NFID designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - See more at: http://www.nfid.org/professional-education/online#sthash.jxk2YaSo.dpuf